Moderna has been under pressure to cut its prices and expand production for poorer countries. Elizabeth Warren, the Democratic senator from Massachusetts, told the Financial Times last month that both Moderna and Pfizer needed to "do more to address the unacceptable disparities in global access to Covid-19 vaccines, including by dramatically expanding vaccine manufacturing around the world".